Kirkland & Ellis advised Bristol-Myers Squibb Company on the agreement with Amgen for Amgen to acquire the global rights to Celgene Corporation’s OTEZLA® for $13.4 billion…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now